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ABSTRACT

DIAGNOSING & TREATING ADHD; DISCIPLINE DIFFERENCES

by
Lisa M. Lliteras-

Doctor ofPsychology, Graduate Program in Psychology
Loma Linda University, September,2010
Dr. Adam Arechiga, Chairperson

According to Barkley(2005), attention deficit hyperactivity disorder(ADHD)is
one ofthe most common reasons children are referred to mental health workers in the

United States and is now one ofthe most prevalent psychiatric disorders associated with
childhood. The diagnostic criteria and labels for ADHD have changed over the last
several decades, and with each change the prevalence rate for ADHD has increased

(Wolraich & Baumgaertel, 1997). This increase in the prevalence of ADHD has led to a
need for clinicians fi^om different disciplines to assess and treat ADHD. As such, several

guidelines from professional associations have been published in effort to create some
consistency in the assessment and treatment of ADHD.Nevertheless research indicates
that there is still substantial variability in diagnosis and treatment strategies within

disciplines as these guidelines have proven difficult to implement. This variability

suggests that there are likely differences in how the different disciplines, i.e., medicine
and psychology, approach diagnosing and treating ADHD.However,no research exists at
this time which has looked at this issue. The purpose ofthis paper therefore is to

investigate the history of how ADHD has been conceptualized over the years, as well as
the various treatment options.

Vll

Introduction

Attention deficit hyperactivity disorder(ADHD)has become one of the most
frequently diagnosed psychiatric disorders of childhood in the United States (Barkley,

2005) and there is indication that the prevalence rate continues to increase(HarpazRotem & Rosenbeck, 2004). The most often cited prevalence rate for ADHD in the
childhood population of the United States is 3-5% (American Psychiatric Association

(A?A), 1994; Barkley, 2005). However,recent estimates based on epidemiologic studies
reveals prevalence rates ranging from 4 to 12% in the general childhood population
(Brown et al., 2001). Varying prevalence estimates led Barkley(1998b)to state that

"because ADHD cannot be strictly defined and precisely and objectively measured, its
true prevalence cannot be accurately determined"(pg. 78). This has led parents,
educators, psychologists and physicians to question why this problem seems to have
increased in the last 30 years. The answer seems to lie in part, to changes that have
occurred to the diagnostic criteria over the last several decades, as the prevalence rate of
ADHD has increased with each publication. This has created a demand for professionals
to assess, diagnose and treat ADHD,specifically psychologists and physicians. However
with the variety of professionals involved in the diagnosis and management of ADHD
they have introduced a wide variety of assessment methods and treatment options.

Historical Perspective of Attention Disorders

According to Singh (2002),the history of ADHD has been "characterized mainly
by the pursuit of a clinical definition"(p. 361). This pursuit is often traced back to the
1902 lectures of George Frederic Still presented at the Royal College of Physicians in

London that were subsequently published (Still, 1902; Armstrong, 1995). In Still's
lecture, he described a group of children he had seen in his clinical practice who he
described as often being aggressive, defiant, resistant to discipline, excessively emotional
and showing little "inhibitory volition"(Armstrong, 1995). The association between
behavioral difficulties and biological causes was hypothesized early in the history of
attention disorders, with Sill attributing these attention and behavior problems to a
"deficit in moral control" which was either genetic in origin or due to a pre- or post- birth
injury.

The link between attentional difficulties and brain injury was again made in
response to a post World War I outbreak of encephalitis in North America in 1917-1918

(Barkley, 1998a). Children who had suffered with Postencephalitic Behavior Disorder
demonstrated a number of behavioral and cognitive symptoms related to attention and

activity, including impaired attention, regulation of activity, impulsivity, memory
disturbances and social/behavioral problems(Armstrong, 1995; Barkley 1998a).
Eventually it was determined that there was a wide range of illnesses (e.g., measles,

epilepsy) and traumatic injuries (e.g., head injury, birth trauma)that contributed to a
variety of cognitive and behavioral disturbances, notjust those related to attention and
activity (Barkely, 1998a). Due to these events, it became popular to think that because
symptoms of hyperactivity, inattention and impulsivity could arise as a result of brain

injury, then brain injury must be the present if these symptoms are evident(Barkley,
1998a).

In the 1940's, Strauss and Lehtinen(1947) produced some influential writings,

asserting that restless and inattentive behavior was evidence of brain damage(Barkley,
1998a). However,the writings were based on their studies of brain injury in a group of
mentally retarded children, who demonstrated symptoms of distractibility and

hyperactivity confounding any meaningfiil interpretation(Armstrong, 1995). Soon the
term "Minimal Brain Damage" was developed to refer to these children, reflecting the

thought that brain damage was a primary feature associated with symptoms of
hyperactivity, inattention, and impulsivity(Armstrong, 1995). According to Armstrong,
use of the term "Minimal Brain Damage" was later replaced with the term "Minimal

Brain Dysfunction" due to a lack of empirical evidence to show brain damage existed in
children showing ADHD-like symptoms. In actuality, those children labeled as MBD
were a heterogeneous group, with children suffering froin a variety of disorders such as

dyslexia, language and learning disorders and hyperactivity(Barkley, 1998a)
In the late 1950'as and early 1960's, the idea that brain damage in children was

causing attentional and behavioral difficulties began to fall out of favor due to critical
reviews (Barkley, 1998a). According to Barkley, the argument against this view was the
lack of evidence of an actual brain lesion in the children exhibiting difficulties.

Furthermore, the 1960's were distinctive in the history of ADHD in that not only marked
the first time Ritalin was used to control symptoms of hyperactivity, but 1968 marked the
sanction of the foreruimer to ADHD "hyperkinetic reaction of childhood" by the
American Psychiatric Association(APA)(Armstrong, 1995).

Attentional difficulties and hyperactivity in children have a long history dating
back to the early 1900s. At that time, these difficulties with attention and hyperactivity,
were thought to have a biological basis. Specifically, the problem was thought to lie

within the brain. This hypothesis persists into the present day. However, when there was
little evidence to support physiological dysfunction in the 50s and 60s, research began to
focus more on enviromnental contributors. Nevertheless, despite evidence to support a

brain dysfunction, treatment was aimed at changing the child's physiology to control
inattention and hyperactivity as the advent of stimulants changed the course of treatment
to the present day.

DSM and Attention Disorders

The Diagnostic and Statistical Manual of Mental Disorders, now in its fourth

edition(DSM-IV, 1994), is generally considered the "gold standard" for defining and
classifying mental disorders and is used by psychiatrists and psychologists throughout the
United States (Carson, Butcher,& Mineka, 1998). Due to the importance of the DSM in
the conceptualization of the ADHD diagnosis, it is important to understand the changes

that have taken place with regard to the criteria that must be met for a diagnosis of
ADHD to be established.

"Hyperkinetic Reaction of Childhood" is generally thought of as the first

diagnostic label of what is today is known as ADHD and appeared in the second edition
of the Diagnostic and Statistical Manual of Mental Disorders(DSM-II)(1968). The
description of hyperkinetic reaction of childhood provided in the DSM-II was far from
comprehensive, however, consisting of only a single sentence: "The disorder is

characterized by overactivity, restlessness, distractibility, and short attention span,
especially in young children; the behavior usually diminishes by adolescence"(p. 50).
With the next revision of the DSM the diagnostic label changed from
"Hyperkinetic Reaction of Childhood" to "Attention Deficit Disorder"(ADD)(APA,

1980). With the changes in diagnostic labels, the criteria for the diagnosis also changed.
The conceptualization presented in the DSM-III was considered tridimensional in nature,

requiring deficits in each of three areas: attention, impulsivity and hyperactivity(Lahey et

al., 1994). This, however, was a problem is that the definitions of inattention, impulsivity
and hyperactivity overlapped to such an extent that their validity as independent
constructs was questioned(Newcom, 1988). Also included in the DSM-111 were more

specific symptom lists, numerical cutoff scores for symptoms, guidelines for onset and
duration of symptoms, and an emphasis on the importance of excluding other childhood
psychiatric disorders before making a diagnosis of ADD (Barkley, 1998a), However,

these improvements were of little real value in clarifying the ADD diagnosis in that the
description of ADD was based on little more than clinical impressions without empirical
support(Lahey, 1998). Furthermore, one of the major changes in the ADD diagnosis that
occurred with the change from the DSM-II to the DSM-lIl, was that the DSM-111 allowed
a diagnosis of ADHD even if the individual did not display symptoms of motor
hyperactivity(ADDAVO)(Lahey et al., 1994). This change seemed to be done arbitrarily,
however, as there was little empirical literature existing at the time to support the
existence of this ADDAVO diagnosis(Lahey & Carlson, 1991).

The publication of the DSM-llI-R(APA, 1987) again marked a dramatic change
in the conceptualization of ADD. Given a lack of empirical evidence to support the

tridimensional conceptualization of ADD presented in the DSM-III, the DSM-III-R
combined the three lists of symptoms in the DSM-III into a single list(Morgan, Hynd,
Riccio,& Hall, 1996). In order for a diagnosis of ADD,the individual had to have eight
out of the fourteen symptoms. Because no subtypes were included, the diagnosis of ADD
without hyperactivity was not possible (Greenhill, 1998). Instead, a separate category of
Undifferentiatied Attention Deficit Disorder(UADD)was created which had no

diagnostic criteria and was described as applicable to ADD not specified by the ADHD
criteria(Lahey, McBumett & Pfiffner, 1993). The result of which, according to Lahey,
McBumett and Pfiffner, was that UADD became an ill-defined, heterogenous category.

Furthermore, as Lahey et al.(1988)asserted, the ADHD and UADD diagnoses were
based on contradictory assumptions. The ADHD diagnosis conceptualized the disorder as
unidimensional, with symptoms of inattentiveness, impulsivity, and hyperactivity
coexisting, while the UADD diagnosis presented a disorder where inattentiveness exists

independently of impulsivity and hyperactivity. Given these criticisms, it is the general
consensus among researchers in this area that the DSM-III-R was published prematurely,

before adequate empirical tests of the DSM-III criteria could be conducted(Morgan et '

al., 1996; Prick and Lahey, 1991; Schaughency and Rothlind, 1991; Lahey, 1988).
While the DSM was undergoing these revisions, many researchers were
conducting factor analyses on the symptoms thought to comprise ADHD. Results of these

studies indicated that the symptoms of attention deficits and motor hyperactivity tend to
load on separate factors, while symptoms of impulsivity loaded on both of these factors
(Carlson and Lahey, 1983; Lahey et al., 1978). Given these results, in revising the criteria
for ADHD for the DSM-IV (1994), the field committee ultimately decided that neither

the unidimensional nor three dimensional models fit the symptomology of ADHD
(Lahey,Pelham, et al., 1988). Instead, ADHD was again reconceptualized, and this time
the symptomology was described in two dimensions, the first composed of symptoms of

inattention and the second consisting of symptoms involving excessive motor activity and
impulsivity(Lahey et al., 1994). This new conceptualization was tested in the DSM-IV
field trials(Lahey et al., 1993) where structured diagnostic interviews involving multiple

informants were conducted on approximately 400 youths. Based on the results of the field
trial, Lahey et al. felt this two dimensional conceptualization of ADHD was superior to

that presented in the DSM-III-R.

According to the criteria set forth in the DSM-IV,to be diagnosed with AI^HD an
individual has to have symptoms of ADHD for 6 months,the symptoms must be

developmentally deviant, and must have developed before the individual was 7 years of
age. From the inattention symptom item list,6 of the 9 items must be endorsed as

developmentally inappropriate for a diagnosis Attention-Deficit/Hyperactivity Disorder,
Predominantly Inattentive Tj'pe. Similarly,6 of the 9 items from the hyperactivityimpulsivity symptom list must be endorsed as developmentally inappropriate for a
diagnosis of Attention-Deficit/Hyperactivity Disorder, Predominantly HyperactiveImpulsive Type(ADHD-PHI). If the individual meets the criteria for both symptom lists,
they are to be given the diagnosis of Attention-Deficit/Hyperactivity Disorder, Combined
Type(ADHD-C). Additionally, a diagnosis of any subtype of ADHD requires that the
child display symptoms of ADHD in two or more settings (e.g., school, home).

The new diagnostic criteria is far from perfect however. For instance, although the

symptom lists were revised for the DSM-IV,empirical support was lacking regarding the

number of symptoms required for diagnosis(Goldman et al., 1998). It should also be
noted that the development and testing of the DSM-IV criteria occurred with children

seen in a psychiatric setting, therefore not as much is known about the typical child that
presents with sjmiptoms of hyperactivity and/or inattention to the pediatrician or family
practitioner(APA). In fact, from the 440 subjects selected for the field trial, 75 were
psychiatric inpatients, 26 were inpatients on a forensic psychiatry unit for juvenile sex

offenders, and 56 were in a state juvenile detention facility (Frick et al., 1994). Thus,this
is hardly the typical child that presents to their pediatrician with an attention or
hyperactivity problem. This is important because in the United States, most of the
children seen for ADHD symptoms are cared for by pediatricians and family
practitioners, while only the more seriously impaired patients, and those that experience
significant comorbidity that are seen by specialists (e.g., neurologists, child psychiatrists)
(Goldman, Genel, Bezman,& Slametz(1998). Furthermore, it should also be noted that

the population used for the DSM-IV field trials had 3 boys for every I girl, which
suggests one should be cautious in generalizing the findings to girls (Frick, 1994).
One concern with the changes that have taken place with the DSM in regard to
ADHD,has been that with each change in the diagnostic criteria for ADHD,more
children have been identified as having the disorder. One study, conducted by Wolraich
et al.(1996), identified the presence of ADHD using both DSM-III-R and DSM-IV

diagnostic criteria in a group of elementary school. The findings indicate that 7.3 percent
of the students met the DSM-III-R criteria for ADHD,while 11.4 percent of the students
met the DSM-IV criteria. Similarly, Lahey et al.(1998)reported that in the DSM-IV field
trials, 26% of children who met the hyperactive-inattentive type of ADHD did not meet

the DSM-III-R criteria for ADHD. Not only does this situation have potential to increase
the prevalence of ADHD,but it creates confusion in generalizing from one diagnostic
system to another as well as making research comparisons across studies (Biederman,
Faraone, Weber, Russel, Rater & Park, 1997).

The DSM-V is anticipated to be released in 2013, but the preliminary versions are
available on line for review(APA,2010). Pilot testing for the DSM-V field trials is

currently underway and they will be moving into the first phase of testing in May,2010.
As it stands, however,there are some changes already proposed for the ADHD diagnosis

leading to year another conceptualization of the diagnosis. One criticism of the DSM-IY
is that it does not reflect the current thinking that inattention and mpulsivity/hyperactivity
are two separate factors under the ADHD umbrella. To address this criticism, several
solutions are being considered. The first is to break the ADHD diagnosis into 3 subtypes,
including a combined type, predominantly hyperactive type and a separate code for
predominantly inattentive type. A second option is to use the existing structure without

the subtypes, but to use behavior specific dimension scores. The third option is to go back
to a unidimensional conceptualization by replacing the predominantly inattentive and

predominantly hyperactive/impulsive types with a Combined ADHD diagnosis. The new
DSM-V will likely include a change in the age of onset date from before the age of 7 to
before the age of 12.

The ADHD diagnosis has a long history, characterized by dramatic changes in

conceptualization. The pattem of change was from a unidimensional conceptualization,

as specified by the Hyperkinetic Reaction of Childhood diagnosis in the DSM-II(1968),

to a tri-dimensional conceptualization as indicated by the diagnosis of Attention Deficit

Disorder, in the DSM-III. This pattern was repeated in the DSM-III-R (1987), where a

unidimensional ADHD diagnosis was presented followed by yet another return to the tridimensional conceptualization of the DSM-FV (1994). This debate is far from over as the

next DSM to be published in 2013 is still considering both unidimensional and tridimensional conceptualizations. This lack of consensus on what symptomology

comprises the ADHD diagnosis has led many to question the validity of the current
ADHD diagnosis, and some to challenge the very existence of the ADHD diagnosis.

Medical Research on ADHD

Because ADHD is often diagnosed by a family physician or pediatrician it is

important to understand how the medical model influences the conceptualization of
behavioral disorders. According to McGuiness(1989), medically trained researchers are
trained under a disease model, which emphasizes that diseases have a single cause.

Research is generally of two designs; correlation, in which case no cause and effect

relationship can be determined, or univariate in which one cause and one outcome are
examined. As a result, medical students may become biased by the disease model and
begin to think in terms of single causes and effects (McGuirmess). According to Barkley
(2005), the medical model has influenced the conceptualization of psychopathology as a

disease state, where the individual either has it or does not(Barkley, 2005). As a result,
when a child with symptoms of ADHD comes into the physician's office, his or her

symptoms of difficulty paying attention are viewed through the disease model; i.e., if a
child is having difficulty paying attention, and the brain regulates attention, then there

must be something wrong with the brain(McGuirmess, 1989). The result is that the
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physician tends to view the child as having the problem, ignoring any familial or

educational influences(McGuinness, 1989). The medical research that has been
conducted on ADHD reflects this type of univariate conceptualization of the illness,

typically focusing on determining either the neurological, physiological or biochemical
causes. In general, the role of the environment and its contributions to the etiology of
ADHD has been neglected (Carey, 1999).
Studies which have focused on finding neurological correlates for ADHD have
focused on determining either the biochemical, structural, genetic or blood flow markers
which differentiate between children with ADHD and those without. According to

Mercugliano,Power and Blum (1999), the neurotransmitters dopamine and

norepinephrine have been implicated in behaviors related to attention span and
impulsivity, and most medications prescribed for ADHD work to increase the level of
these neurotransmitters in the brain. Despite this, studies which measure the level of

dopamine and norepinephrine or their metabolites in blood ixrine or cerebral spinal fluid
have not demonstrated consistent results in differentiating between individuals with and

without ADHD.Studies which seek to identify structural markers of ADHD rely largely
on neuroimaging techniques. According to Barkley(1998b), coaxial tomographic(CT)
scans have not been able to show gross neurological differences between children with
and without ADHD. Although finer grained analysis with MRl some studies have found

those with ADHD to have smaller corpus callosums and caudate nuclei (e.g., Hynd, Hem,
Novey, Eliopulos, Marshall, Gonzalez & Voeller, 1993), these results have proven
inconsistent across studies (Barkley, 1998b). Researches on the genetics of ADHD
indicate that there is some genetic contribution to the diagnosis. According to Nakamura
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(2002), approximately 50% of parents who had ADHD as a child have a child with

ADHD and between 10 and 35% of children with ADHD have a first degree relative who
has been diagnosed with ADHD. However,the specifics of this genetic contribution have
not yet been identified. Banaschewski et al.(2005)reported that the known risk alleles
are widely distributed in the population and only account for a small increase in risk, with

no single allele considered necessary or sufficient for the development of ADHD. Other
researchers have concentrated on demonstrating differences in cerebral blood flow
between children with and without ADHD. Several researchers (e.g., Lou, Henriksen,&

Bruhn,1984; 1990)have foimd diminished blood flow in the prefrontal regions as well as

the pathways connecting these regions to the striatum and the caudate nucleus. However,
these results have proven inconsistent when applied to non-adult populations, and it is
thought differences are not indicative of deviations (Zametkin et al., 1990). Additionally,
according to Zametkin et al., differences in brain function have been found in children

without ADHD,therefore it is not possible to determine whether a brain variation is an
indication of the presence of ADHD or just a normal variation. In general, most studies
which have focused on the possible neurological indications of ADHD have lacked large

sample sizes as well as proper methodological controls for inclusions of children with
various psychiatric disorders(Brown et al., 2001).

According to McGuinness(1989),the fact that there are no "consistent

physiological or biochemical indicators for any diagnostic category has been an
intractable problem for modem psychiatry"(pg. 151). As a result, Mercugliano,Power
and Blum (1999)suggest that ADHD should be viewed as strictly a behavioral diagnosis

as there are no "medical tests, physical examination findings, office-based psychological
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tests or neurological tests that are both sensitive and specific for ADHD"(pg. 7). As a

result, the American Academy of Pediatrics(2000)recothmended that laboratory and
medical tests not be routinely used in evaluating a child for ADHD. Therefore, according

to Mercugliano,Power and Blum, it is the clinician's responsibility to make judgments of

whether the behaviors that are thought to comprise ADHD (i.e., hyperactivity,
inattention, and impulsivity) are occurring with enough severity and at a level that is

developmentally inappropriate. This requires therefore, that the person providing the
diagnosis be familiar with normal development and behavior, that they gather
information from several sources for the assessment of the child's behavior in a number

of different settings, as well as determine a potential differential diagnosis that may
explain the child's difficulties(Goldman, Genel, Bezman & Slanetz, 1998).
As of yet, no pathophysiological pathways have been identified as unique for
ADHD and therefore, there are no definitive medical tests(Banaschewski et al., 2005).

This is likely because there is no one cause of ADHD symptoms, but rather an interaction
between physiological and environmental factors. The tendency of the medical
community to view problems through a univariate causal model therefore is too simplistic
to explain the complexity and variations of ADHD. This has likely contributed to lack of
definitive progress in determining biological correlates for ADHD.

Difficulties in Diagnosing ADHD
One of the difficulties in diagnosing ADHD is related to the heterogeneous nature

of the symptoms thought to comprise the illness. One controversy surrounding ADHD

concerns whether its symptoms comprise what is considered a behavioral syndrome. The
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term syndrome refers to a group of symptoms that co-occur(Carson, Butcher, and
Mineka, 1998). As briefly discussed previously, some literature suggests that ADHD is

actually comprised of two entirely different syndromes: One involving primarily

symptoms of inattention and the others comprised of symptoms of hyperactivity and

impulsivity(Lahey et al, 1994). In support of the idea that ADHD is actually comprised
of two different syndromes,there is evidence to suggest that the two dimensions of

ADHD are associated with different types of impairment. Specifically, Lahey et al. found
the hyperactivity-impulsivity subtype to be associated with global ratings of impairment
and the inattention subtype to be associated with academic impairment. Further research
has demonstrated an association between the combined subtype and problems of

persistence in effort and distractibility(Barkley, 1998b). Additionally, the different
subtypes seem to have different trajectories at different developmental levels, with
symptoms of hyperactivity tending to decline over time while symptoms of inattention
decline less so(DuPaul et al., 1997)individuals that initially meet criteria for the
hyperactive-impulsive subtype are sometimes reclassified as predominately inattentive as
they get older (Barkley, 1998b). There are also age differences between the two types,
with those individuals diagnosed as the predominantly hyperactive-impulsive(ADHD-

PHI)being mainly preschool age children while those diagnosed with the combined

subtype(ADHD-C)being primarily school-aged children(Lahey et al., 1994).
Another factor which makes the assessment of ADHD complex is that amount

and type of disorders that commonly co-occur with ADHD.Bird, Gould, and Staghezza
(1993)describe the current child psychiatric diagnosis as one that "leaves much to be
desired in terms of the validation of diagnostic entities that can truly be distinguished
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from one another"(pp. 361). According to the American Psychiatric Association(2000),

those disorders that most often co-occur with ADHD include oppositional defiant
disorder, conduct disorder, depression, anxiety, and several developmental disorders,

such as speech and language delays as well as learning disabilities. In fact, according to
Szatmari, Offord and Boyle(1989), up to 44% of children diagnosed with ADHD have at
least one other psychiatric disorder, 32% have two disorders, and 11% have at least three

other disorders. The issue of comorbidity is further complicated by the fact that different
disorders tend to co-occur with different subtypes (Eiraldi, Power,& Nezu, 1997).
Further complicating the issue is that the main symptoms of ADHD (i.e., inattentiveness,

hyperactivity, and impulsivity) are commonly seen in children with other psychiatric
disorders such as schizophrenia, bipolar disorder and the pervasive developmental
disorders (Perry et al., 2000)

The issue of comorbidity has both diagnostic and treatment implications and adds
a degree of complexity to the process. To determine if a comorbid condition exists
requires the clinician to obtain a thorough history of behavioral symptoms, an assessment
of cognitive, achievement and speech and language functioning, as well as a physical and
neurological examination, including an evaluation of motor abilities(Wolraich &
Baumgaertel, 1997). According to Wolraich and Baumgaertel, this is particularly
important when working with children who are suspected of having mood or anxiety

symptoms, or who have a learning disability, because these problems can actually cause
ADHD-like symptoms. A clinician or physician must be aware of subtle behavioral
differences that exist in children who have a comorbid condition(s)for a correct

diagnosis to be made. For example, children with anxiety may exhibit features such as
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restlessness, irritability and difficulty concentrating (Searight, Nahlik,& Campbell,
1995). However, a child with an anxiety disorder will be less likely to be impulsive and

act out behaviorally and more likely to be socially withdrawn and exhibit somatic
complaints.

Some researchers have stated that symptoms of ADHD are not readily

distinguishable from normal variations in temperament(Carey, 1998). In fact, the DSMIV-TR(APA,2000)does not specify the degree of impairment the child needs to have to

warrant the ADHD diagnosis. According to Armstrong (1997), 10 to 20% of children
can be considered as having a difficult temperament, which involves the child possessing
characteristics such as high activity level, distractibility, high intensity, and low sensory
threshold to name a few. However,by themselves, these traits do not necessarily mean
the individual has a disorder(Carey, 1998). It is when there is a poor fit between the child
and his environment, i.e., parents, teachers, classroom, exposure to multiple stressors,
etc., that the child exhibits behavioral disturbances (Armstrong, 1995; Carey, 1998). The
difficulty lies in that a diagnosis of ADHD relies on a subjective determination of

whether a child's symptoms constitute a behavioral disorder or a normal variation in
temperament.

ADHD has a number of characteristics that make it particularly difficult to

diagnose. The symptoms can sometimes be subtle and difficult to distinguish from
normal variations in temperament and there are comorbid conditions and differential

diagnoses to consider when assessing for ADHD. With so much to consider, it is

important to have a thorough approach when arriving at an ADHD diagnosis.
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How an ADHD Diagnosis is Established

Given the degree of ambiguity surrounding the diagnosis of ADHD,it is
unfortunate that process of assessing for the presence of ADHD is equally ill defined.
Although most research suggests that a comprehensive evaluation incorporates different
informants and a variety of procedures, such as interviews, rating scales, educational
assessments and observation, there is no specific test for ADHD (Greenhill, 1998;
Schaughency & Rothlind, 1991). Therefore, the clinician is left to determine their own
protocol for evaluating children for ADHD.Even those organizations that have put forth

guidelines for the assessment and treatment of ADHD,have stated that they are not to
replace the judgment of the clinician(AACAP,2007). Unfortimately, the result is that
there is a lot of variability in how assessments are done. The likely outcome is that some
children are receiving comprehensive evaluations, while others are being diagnosed with
ADHD without much assessment at all. While this variability presents the problem of

inaccurate diagnoses, this becomes especially important when considering the cost and
potential side effects that may be a result of taking medication for ADHD.
One thing most clinicians are able to agree upon is the need for several types of
assessments for establishing a diagnosis of ADHD,commonly referred to as a multimethod assessment(Anastopoulos & Shelton, 2001). Specifically, a multi-method

approach utilizes both multiple assessment methods and multiple informants(Weyandt,
2001). According to Anastopoulos and Shelton, these methods generally include clinical

interviews, behavior rating scales, psychological tests, observational techniques and
various medical procedures. However, because the DSM-IV does not specify which

assessment methods or procedures should be utilized for establishing a diagnosis, the
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decision about what methods to use lies with the clinician and is therefore subject to

interpretation (Anastopoulos & Shelton, 2001). Schaugheney and Rothlind (1991)
recommend the diagnosis of ADHH be considered a "best estimate" diagnosis and should
be based only on a multimethod assessment strategy.
According to Anastopoulos & Shelton, 2001, the clinical interview is the

foundation of mulitmethod assessment and is generally administered to parents or
caretakers, the child or adolescent who is suspected of having a disorder, and/or teachers.
Clinical interviews differ in the way they are conducted. Structured interviews follow a

standard format of administration, in which the clinician reads all the questions exactly as
they're written and in the order in which they are intended to be read (Anastopoulos &
Shelton, 2001). According to Anastopoulos & Shelton, one structured interview that has

dominated the field for the past 20 years is the Diagnostic Interview Schedule for
Children-IV (DISC-IV). The DISC-IV is a highly structured interview designed to assess

more than 30 psychiatric disorders in children and adolescence (Shaffer, Fisher, Lucas,
Dulcan & Schwab-Stone, 2000). The DISC-IV was designed to elicit responses that are
relevant to a number of DSM-IV defined psychiatric diagnoses for children and

adolescents (Anastopoulos & Shelton, 2001). While this is generally viewed as a strength
of these instruments, it assumes that the DSM-IV criteria are valid and reliable.

One difficulty with the use of structured clinical interviews has to do with their

length and therefore the time required for their administration, which can take 2 to 3
hours (Jensen & Weisz, 2002). For that reason, according to Jensen and Weisz, their use
is often restricted to the research setting, where diagnostic comprehensiveness is an
important goal. This is in contrast to the clinical setting, in which third party
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reimbursement requires a diagnosis, and at the same time creates workload and time

constraints that prohibit a comprehensive assessment. Even if clinical interviews were

feasible given the setting, their utility is questionable in that there is generally poor
agreement between elinician diagnoses and diagnoses derived standardized interviews

(Jensen and Weisz, 2002). Furthermore, given that there is no gold standard for valid
diagnoses, it is impossible to tell which diagnoses are more accurate(Jensen & Weisz,

2002). Additionally, Jensen and Edelbrock(1999)found that the respondent to the DISC
interview is likely to deny the existence of a particular symptom as a function of the

question placement within the interview. More specifically, as the respondent gets further
into the interview, they are less likely to endorse a particular symptom. Jensen and
Edelbrock(1999) propose that this phenomenon results because the respondent becomes
aware that endorsing another item will generate many additional questions they must
answer.

As an alternative to structured interviews, there are semi-structured and

unstructured interviews, which require much less time for administration that do
structured interviews and are therefore more commonly utilized in the clinical setting
(Jensen & Weisz). Semi-stxuctured interviews involve the clinician asking the parent
preplanned questions regarding the child's history and current functioning, but do not
follow a standard format. One of the most well-known semistructured interviews is the

Semistructured Clinical Interview for Children and Adolescents(SCICA)(McConaughy
& Auchenbach, 1994). However,the SCICA has low inter-rater reliability for the
Attention Problems scale (.57) and does not map closely with the DSM-IV criteria

(Anastopoulos & Shelton, 2001). Unstructured interviews are probably the most popular
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among elinicians because they allow complete freedom and flexibility in what is asked

(Anastopoulos & Shelton, 2001). However, Anastopoulos & Shelton caution against
using unstructured interviews for the diagnostic portion of the assessment because there
is too much variability in what information is covered during the interview as well as
how the material is covered.

Rating scales and child behavior checklists are another type of assessment

instrument which allow the clinician a means of quantifying the opinions of parents and
teachers and compare them to standardized norms(Barkley, 1998b). Two of the most

commonly used broad band rating scales are the Connors Rating Scales (Coimers, 2008)
and the Achenbach System of Empirically-Based Assessment(ASEBA). The Coimers

Rating Scales consist of both long and short forms for parents, teachers and adolescents,

as well as an ADHD index (Anastopoulos & Shelton, 2001). According to (Anastopoulos

& Shelton, 2001)the ADHD index consists of 12 items that are thought to distinguish

those children with ADHD from those children without it. Additionally, this index is
combined with the DSM-IV criteria to form several shorter scales called the Conners'

ADHD/DSM-IV scales(CADS)of which there are versions for parents, teachers and
adolescents to complete. The ASEBA,like the Conners' scales also includes different
rating scales for specific informants. Specifically, there is a Child Behavior Checklist for

Parents(CBCL),A Teacher's Report Form (TRF), and a Youth Self Report(YSR)for the
older children and adolescents (Kronenberger & Meyer, 1996). The CBCL includes items
that are essential features of ADHD (e.g.. Attention Problems Subscale) as well as
associated features (e.g.. Aggressive Behaviors and Social Problems Subscales
(Kronenberger & Meyer, 1996).
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Because the diagnosis of ADHD requires that the individual display impairment
in two or more settings, such as school, home,and/or extracurricular activities, the rating

scales are particularly useful. In fact, only about 20% of children with ADHD exhibit
symptoms in the physician's office (Sleator & Ullman, 1981), and clinicians typically
have time constraints which make it impossible for he or she to observe the child
firsthand at school and in the home. Therefore, these rating scales serve as an important

means of determining the child's typical behaviors, as well as the scope of impairment, in

multiple settings. Of course this raises concems regarding the validity and reliability of
these reports. In a study conducted by Biederman, Faraone, Milberger and Doyle (1993),
they found only a .22 agreement between parent and teachers for specific symptoms of
ADHD.One reason for this low correlation may be that it is often difficult to obtain a

meaningful teacher's report due to time constraints(on the part of both teachers and
clinicians), teacher unavailability, as well as limited time spent with the student due to
multiple teachers (Faraone, Biederman,& Milberger, 1995; Mitsis, McKay, Schultz,
Newcom,& Halperin, 2000). Additionally, when symptom reports are compared between

the parent and child with the suspected disorder, it has been found that parents report

symptoms of ADHD nearly twice as high as those made by children and adolescents
(Gittelman and Mannuzza, 1985).

Another way clinicians have attempted to test for the presence of ADHD is with
the use of Continuous Performance Tests(CPTs)(Kronenberger & Meyer, 1996).

According to Kronenberger and Meyer,there are many types of CPTs, but they all

involve having the child sit in front of a computer screen while letters or numbers appear

quickly on the screen. The child is required to press a button when a certain sequence of

21

stimuli appears. Then the amount of correct responses, or hits, is calculated, along with
the amount of misses(when the child was suppose to respond but did not), and errors of
commission(when the child was not supposed to respond but did not)(Kronenberger &

Meyer, 1996). According to Kronenberger & Meyer, 1996, hits are thought to measure
sustained attention, misses are a measure of distractibility, and errors of commission are a

measure of impulsivity. Despite the perceived usefulness of CPTs,the American
Academy of Child and Adolescent Psychiatry(1997)does not recommend their use in the
assessment of ADHD because they have problems with low specificity and sensitivity.
Similarly, the American Academy of Pediatrics(2000)has also warned against their use

because CPTs are not consistently able to distinguish between children with ADHD and
normal controls. Nevertheless, CPTs are commonly used.

Part of the responsibility of the clinician who assesses children for ADHD is to
mle out other potential diagnoses. The DSM-IV (2000)recommends that any medical

disorders that may associated with the inattention and impaired behavioral control should
be ruled out prior to making an ADHD diagnosis. Specifically, the child's prenatal and
birth histories should be reviewed and it should be noted if the child has ever been

evaluated for allergies, seizure disorder, hyperthyroidism, diabetes, anemia and

hypoglycemia(Monastra, 2008; Greenhill, 1998: AACAP, 1997). Additionally, it is
important for the clinician to note any brain injuries since traumatic brain injury is
considered a risk factor for ADHD and ADHD-like behavior(Morgan, 1999).

In addition to ruling out any medical causes that may mimic the symptoms of
ADHD,the clinician needs to be aware of any comorbid conditions that may exist. As

stated previously, there are many psychological conditions which often co-occur with
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ADHD including oppositional defiant disorder, conduct disorder, depression, anxiety,

several developmental disorders, such as speech and language delays as well as learning
disabilities(APA,2000). It is therefore very important that the clinician assessing the
child is familiar with the symptoms of each of these possible comorbid conditions as well
as assessment tools for evaluating these conditions. While it is beyond the scope of this

paper to discuss assessment tools and techniques for each of these disorders, however
there are some general guidelines. Morgan(1999)recommends assessing the child's

cognitive and academic abilities to rule out possible learning disabilities that may be
contributing to, or even causing the child's problem. Intelligence in a child suspected of

having ADHD can be evaluated using the Wechsler Intelligence Scale for Children. For
the purpose of ruling out a learning disability an achievement test can be administered

such as the Woodcock Johnson, Wide Range Achievement Test, or WIAT-III. The
presence of other disorders, such as oppositional defiant disorder, conduct disorder,

depression, and/or anxiety can be assessed by the Child Behavior Checklist or other
broad-band instrument and additional syndrome specific tests on an as-needed basis
(Kronenberger & Meyer, 1996).

The assessment process for ADHD is long and can be complicated. There is no
one standardized approach, but at the same time, there are certain factors that must be

considered. Specifically, the assessment process must involve multi-method assessment

with multiple informants. However, it is up to the clinician to be familiar with the variety
of assessment tools and methods, and to be able to draw valid conclusions from the

results. However, when one considers how many different disciplines diagnosis ADHD
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and the variations in training between the disciplines it becomes apparent that there is not
much consistency in how ADHD is assessed.

Who Diagnosis ADHD

ADHD has historically been considered a psychiatric disorder and as such,
ADHD cases were managed by psychiatrists(Koonce,2007). However,the increased

prevalence of ADHD has resulted in increasing numbers of different professions
managing the number of cases(Centers for Disease Control and Prevention, 2005). These
professionals are tj'pically school psychologists, clinical psychologists, general practice
physicians, pediatricians and individuals with advanced nursing degrees. While this

increase in professionals has been necessary from a practical standpoint, it should be
noted that diagnostic practices vary greatly according to the specialty of the person
making the diagnosis (National Institute of Health, 2001). A lack of standardization of

assessment for ADHD makes conclusions about individual cases difficult and prevalence
rates almost impossible to accurately determine.
In effort to standardize the care of children being seen for ADHD within the
medical care setting, several orgaiiizations have sought to establish guidelines for the
assessment and treatment of ADHD.The American Academy of Pediatrics(AAP)

published evidenced based guidelines for the diagnosis and treatment of ADHD in 2000.

The most recent practice parameters were published in 2007 by the American Academy
of Child and Adolescent Psychiatry(AACAP). According to these guidelines, the child

must meet the DSM-IV criteria for ADHD and as such a general assessment should

include a review of the child's medical,family, social and academic history, a thorough
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parental interview, behavioral checklists from teacher and caregivers and an evaluation
for comorbid disorders. Neurological, neuropsychological or any laboratory tests are not
indicated unless there is a rationale behind it, such as head injury or lead exposure.

While no research as of yet has focused on adherence to the AACAP guidelines,
the AAP guidelines proved difficult to implement in everyday practice(Rushton, Fant
and Clark, 2004). Specifically, Leslie, Weckerly, Plemmons, Landsverk and Eastman

(2004)implemented the AAP guidelines in seven primary care offices in the San Diego
area for the pmpose of evaluating the feasibility of adopting these guidelines in a working
practice. Leslie et al. found that individuals in primary practice felt they had limited
information regarding guidelines for diagnosing ADHD,specifically with regard to
assessment instruments, comorbid conditions and guidelines for referring for

psychoeducational testing. There was a sense among these primary care providers that if
they explored psychosocial issues in too much detail they would be ill-equipped to assess

or manage coexisting conditions. This issue is especially a concern within the context of
a typical physician appointment, which allows 7 to 15 minutes per child. As such,
Kwasman, Tinsley, and Lepper(1995)reported that 60% of physicians surveyed reported
the necessity of setting aside time to care for ADHD patient.
Other research has confirmed that the AAP guidelines are difficult to successfully
put into practice. One of the recommendations of both the AACAP and the AAP is that

the child must meet the DSM-IV criteria for a diagnosis of ADHD.Studies that have
surveyed pediatricians regarding diagnostic practices found that 20 to 36% adhered to

DSM-IV criteria(Copeland et al., 1987; Wolraich et al., 1990). Furthermore, the
application of practice guidelines varies within medical specialties. Specifically, Rushton,
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Fant and Clark(2004)investigated the use of practice guidelines between pediatricians
and family practice physicians. Rushton et al. found that 91.5% of pediatricians were
familiar with the guidelines, and 78.1% they had incorporated these guidelines into their
practice. In contrast, 59.8% of the family practice physicians were familiar with the
guidelines with only 39% having put those guideline to practice. This difficulty in
utilizing the guidelines is not limited to physicians, but extends to other health care

providers such as nurse practitioners. For example, Vlam et al, found that only 64% of
respondents utilized DSM-IV criteria in arriving at a diagnosis of ADHD and only 22%
reported using multiple measures in arriving at a diagnosis of ADHD.

This variability in diagnostic practices is not limited to the medical field, but
extends to psychologists as well. Researchers who have surveyed how psychologists
arrive at a diagnosis of ADHD have found that 61% strictly adhere to the DSM-IV
criteria(Handler and DuPaul, 2005). Furthermore, Handler and DuPaul found that 93%

of psychologists surveyed indicated they regularly used parent interviews and 92% stated
they used child interviews and standardized rating scales. Variations in practice also exist
within the field of school psychology. For example. Handler and DuPaul(2005)reported
that school psychologists tend to use more direct school observation than do clinical
psychologists. Furthermore, school psychologists tend to use more intelligence and

achievement testing for the purpose of assessing possible learning disorders(Koonce,
2007).

When assessing ADHD symptoms professionals tend to agree that the "best

practice" involves a multimethod approach across multiple settings and informants to
gather information regarding the presence, pervasiveness, chronicity and impairment as
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specified in the DSM-IV-TR(2000)(Handler & DnPaul, 2005). Nevertheless, research
indicates there is still a lot of variability in the way ADHD is assessed both between and

within professions(See Table 1 for Adherence to DSM-IV criteria by discipline). Some
of this variability seems to have to do with not being aware of current guidelines as well
as with the time required to conduct a thorough ADHD assessment. These differences in

diagnostic practices make prevalence rates difficult to determine and result in children
either being underdiagnosed or provided treatment they do not need.

Table 1

Adherence to DSM-IV Criteria When Making an ADHD Diagnosis by
Practitioner Type

Nurse Practitioners

64%^

Psychologists

61%''

Pediatricians

20-36%"''

''Vlam,2006

"Handier & DuPaul, 2005
" Copeland et al., 1987
'* Wolraich et al., 1990

As the prevalence of ADHD is increased, there have been a variety of
professionals who have become involved in the diagnosing ADHD.In effort to
standardized the process, several organizations such as the AAP and the AACAP have
created guidelines. However,these guidelines still allow a certain amount of freedom in

how they are applied in practice leasing to variation in practice. Furthermore, it does
seem unlikely, that these guidelines can be incorporated into the 7 to 15 minutes window

that comprised the typical physician appointment. Therefore, the physician who evaluates
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and treats ADHD will have to institute changes in how their practice operates.
Psychologists, who are treated in assessment and treatment, and who typically have

longer appointments may be a more appropriate choice for the management of ADHD.

Treatment of ADHD

Treatment for ADHD typically involves medication, behavior therapy and/or
parent training. According to the AACAP(2007) pharmacological treatment involves the
use of a stimulant or one of the newer non-stimulant medications used to treat ADHD.

Less commonly, an anti-depressant may be tried in cases where stimulant treatment is
contraindicated or ineffective. The medications used to treat ADHD are usually divided

into short and long acting preparations and both are thought to be equally efficacious
(AACAP,2007). However,the short acting medication often requires multiple

administrations throughout the day, but is safer to use with younger children.
Psychosocial interventions typically consist of behavior therapy which includes parent
training, classroom interventions, academic interventions and peer interventions(Brown

et al., 2008). According to Anastopoulos and Shelton(2001), most parent training
consists of teaching parents to use positive reinforcement of appropriate behaviors,
response cost for inappropriate behaviors, and the use of time-outs. There are a number of

classroom interventions, with the most common being the use of daily report cards and
some type of point or token system (DuPaul & Stoner, 2004). Academic interventions or

accommodations involve the modification of task demands, providing the child choice in
deciding what task to work on and tutoring(Brown et al., 2008). According to Brown et
al.(2008), peer intervention typically focus on social skills and problem solving and is
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provided either in an after school, weekend or camp setting. Psychosocial interventions
are typically carried out by a psychologist, social worker, or marriage and family
therapist.
Given that nonpharmacological treatments haye been shown to be effective in the

treatment of ADHD,and pharmacological treatments have been associated with a large
number of aversive and potentially dangerous side effects, it would seem that behavioral
treatments would be the treatment of choice. However,this has not been shown to be the

case. In a survey conducted by Wolraich et al.(1990)of pediatricians and family

practitioners, it was found that stimulant treatment is the main treatment prescribed for
children with ADHD.The DBA (2000)reported that more than 50 percent of all

methylphenidate and amphetamine prescriptions were written by pediatricians. In fact,
most children diagnosed with ADHD by a physician during a visit are prescribed a

stimulant during that same visit(Zito et al, 1999), and the lifetime prevalence of
stimulant treatment for children diagnosed with ADHD is 60 to 75% (Safer, 2000).

According to Wolraich et al.(1990), in the primary care setting there is a "serious
underuse" of systematic behavioral treatments. Because the frequency with which
children with psychosocial problems being treated by primary care physicians is growing,
while the number of those children receiving specialty mental health services is declining

(Gardner et al.; 2000), the use of pharmacological treatments for ADHD will likely
continue to increase.

Not surprisingly, pharmacological treatments are more common for those children

who have a physician monitoring their care (Table 2 shows the type of treatment
associated with each of the disciplines)(Zito et al, 1999). Behavior therapy is typically
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provided by a psychologist, master's level therapist, or social worker(Brown,
Antonuccio, DuPaul, Firstad & King (2008). Therefore, a parent's approach to treatment

is largely determined by the type of professional they initially consult. It seems a better
standard of care could be provided if there was more integration and collaboration
between disciplines.

Table 2

Practitioner Type by Typical Treatment Strategies

Physicians
Psychiatrists
Psychologists
Therapists
Social Workers

Pharmacological

Behavior

Parent

Treatments

Therapy

Training

Psychoed

Child

V
V

V
V

V
V

V
V

V
V

V
V

V

V

V

V

V

V

Therapy

Classroom

Interven.

Peer

Interven.

V
V

The use of medication to treat ADHD-like symptoms is certainly not new.

According to Mayes and Rafalovich (2007),the first time stimulant medication was used
with children was in a home for children with emotional problems in 1937called The

Bradley Home(See Appendix B for a timeline). The medication, an amphetamine called
benzadrine, was used to relieve the headaches in children who had undergone a spinal

tap. The benzadrine did little to help the headaches, but resulted in better behavior overall
in these children. Specifically, Mayes and Rafalovich reported that the children exhibited
better work habits, an increased interest in school, and a reduction in disruptive behavior.

Furthermore, according to Schachar(1986), this effect on improving behavior was not

limited to a particular disorder, so it was soon used with children who had a wide range
of diagnoses. According to Mayes and Rafalovich (2007),these findings opened areas of
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research on stimulants and their calming effect on behavior and the stimulant effect on
academic performance.

According to Conrad (1975)the treatment for ADHD was available long before a
disorder was conceptualized. In fact it was not until the 1950's when researchers that

worked at The Bradley Home developed the diagnosis of Hyperkinetic Impulsive
Disorder. Hyperkinetic Impulsive Disorder was characterized by a short attention span
and poor concentration, particularly at school and was thought to be the result of some
type of brain dysfunction, hi the 1940's, a Swiss pharmaceutical firm called, J.R. Geigy
(now known as Ciba) began working on a drug that had a similar stimulant effect to

amphetamine, but with less side effects and potential for abuse. Geigy succeeded in 1955
in creating methylphenidate, brand name Ritalin(Freedman, Effron & Bender, 1955). In
1961, the Federal Drug Administration approved the use of Ritalin for the treatment of

disturbed children(Swanson, McBumett, Christian & Wigal, 1995). The 60's and 70's
were marked by aggressive marketing in medical journals for medical treatment of
ADHD symptoms(Smith, 2008). Between 1972 and 1987 the rate of stimulant treatment
for ADHD rose fivefold (Safer and Krager,1992)

There are other indications that the pharmaceutical companies are very influential
in what information the public gets regarding the treatment of ADHD. According to the

DBA (1995), CHADD began in 1987 and became the nation's largest ADHD support

group, currently boasting over 20,000 members across the country. Also according to the
DEA,Ciba-Geigy(the manufacturer of methylphenidate or Ritalin) contributed $748,000

to CHADD from 1991 to 1994. This contribution has led some individuals to question
whether CHADD is biased towards the medical treatment of ADHD(Heam,2004). One
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such indicator is that the literature produced by CHADD strongly supports the use of
medication for the treatment of ADHD and minimizes side effects and issues of abuse

(Heam,2004). In fact, Heam reported that Shire Pharmaceuticals, the makers of
Adderall, buys 65,000 to 100,000 copies of CKLADD's magazine Attention! and

distributes them in doctors' offices. When leading ADHD researcher William Pelham
was interviewed by the magazine, his discussion of the risks of stimulant treatment and
the recommendation that psychosocial treatments should be tried before using medication
was left out(Heam,2004). Furthermore, CHADD,in conjunction with the American

Academy of Neurology, submitted a petition to change Methylphenidate from a Schedule
II to Schedule III, thereby making it easier to prescribe(DEA, 1995). Furthermore, The
DBA reported that in 1993 the production quotas for Methylphenidate had not been

revised to keep up with demand and there was a revision pending to manufacture more.
However, Ciba-Geigy issued a press release and 400,000 letters to health care
professionals stating that the DEA was creating a shortage of Ritalin. Also according to
the DEA (1995)Ciba-Geigy contacted CHADD asking them to write their congressional
representatives and the DEA to complain about the shortage. At the same time, parents
whose children who were taking methylphenidate became worried about the possibility
of not being able to get the medication. This resulted in parents seeking multiple

prescriptions for methylphenidate in order to ensure they did not run out ultimately

resulting in more sales for Ciba-Geigy(DEA, 1995).

Despite the popularity of medication it is not without drawbacks. Specifically, the
medications that are usually prescribed for the treatment of ADHD are stimulants, such as

methylphenidate (Ritalin) and amphetamine (e.g, Adderall and Dexidrine), and are on the
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Drug Enforcement Agency's(DBA)Schedule II substances because they have the
highest potential for abuse and dependence of medically useful dmgs (DBA,2000).
Because these stimulant medications are classified as schedule II substances, the DBA

keeps careful track of their rate of production. According to the DBA (2000), the United

State's production of amphetamine (primarily Adderall) has increased 2,000 percent in
the last nine years. The effects of both methylphenidate and amphetamine are nearly
identical to those of cocaine(DBA,2000). In fact, in animal studies, rats have been

shown to prefer methylphenidate (Ritalin) over cocaine(DBA, 1995). This has not gone
unnoticed by individuals with legal prescriptions for the medication, as well as those
seeking to use the drugs recreationally. In fact, the DBA reported that in 1994, more high

school seniors in the United States were abusing methylphenidate than those with
legitimate prescriptions(DBA,2000). These stimulants are often abused by crushing and
snorting the tablets for a quick and powerful effect(DBA, 1995). Because
methylphenidate is only available by prescription, unlike other amphetamines which are

often manufactured in individual labs, the only way to obtain it is by diverting it from
legitimate sources (e.g., individuals with a prescription(DBA,2000). This is often
accomplished by theft, of individuals, pharmacies, schools, etc., as well as by scams
involving doctor shopping and faking of ADHD symptoms for the purpose of obtaining a
prescription(DBA,2000).

ADHD medications are associated with many side effects. The short-term side
effects of ADHD medications include increase in blood pressure and heart rate, insomnia,

weight loss, loss of appetite and motor tics(DBA, 1995). However, it may be the longterm side effects of stimulant use in children and adolescents that are more concerning.
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One of the concems over stimultot use for children and adolescents is the long-term
effects have not been researched extensively (Bennett, Brown, Graver and Anderson,
1999). According to Bennett et al. this is due to methodological issues and the reluctance
of parents to enroll their child in a controlled study in which there is chance their child

might be assigned to a control condition. Therefore, what is known about the long-term

effects of stimulants is limited to follow up studies. According to Heam (2004), the MTA
follow up study found that the long-term use of stimulant stunts growth in children at a

rate of approximately one inch every two years. Brown and Sawyer(1988)found no
long-term stimulant effects on academic achievement, interpersonal functioning,
aggression or delinquency. One of the more troubling long-term side effects of long-term
stimulant medications is its effect on the cardiovascular system. The short term
cardiovascular effect of stimulant medication is an increase in heart rate, blood pressure
and respiration(Bennett et al., 1999). Long term use of methamphetamine(a type of
stimulant) can result in myocardial infarction, stroke or sudden death (Nissen, 2006).
Therefore, when cases of children and adults being treated medically for ADHD died
suddenly, the FDA began an investigation. The FDA found that between 1990 and 2000,

there have been 186 sudden deaths of individuals taking amphetamine and
dextroamphetamine (Adderall), methylphenidate or atomoxetine (Strattera)(Baughman,
2001). After investigating these deaths, the Food and Drug Administration(FDA)
requested a "black box" warning in the form of a package insert for stimulant
medications warning that the medication not be used in children with known cardiac
problems (Vitiello and Towbin,2009).

In effort to develop a standard approach to treatment of ADHD,several
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conferences have convened in an attempt to determine the best approach. The first of
such conferences was convened by the National Institutes of Mental Health in 1990 and
is generally referred to in the literature as the MTA study (Multisite Multimodal
Treatment Study)(MTA Cooperative Group,1999a). This study examined the response of

579 children diagnosed with ADHD Combined Type to medication, behavioral treatment,
medication and behavioral treatment, and community care over a period of 14 months.
The MTA Cooperative Group reported findings that the children receiving medication
and combined medication and behavioral treatments had significantly better outcomes
than those children who received behavior therapy alone or commimity care. This study,
although ten years old now, was important in that the results were widely publicized and

used to justify the use of stimulants for the treatment of ADHD. Unfortunately, the
significant methodological flaws of the study did not receive the same publicity. Two of

the most glaring flaws were the omission of a placebo control group and the lack of
double blind procedures (Breggin, 2000).

The more recent practice parameters for the treatment of ADHD recommended a
comprehensive approach using pharmacology, behavior therapy, school-based

interventions, and family and individual therapy(AACAP,2007). The most widely used
intervention for ADHD is pharmacological treatment because of its efficacy(Brown et

al., 2008). Greenhill(2002)reported that double-blind, placebo controlled trials which

examined the efficacy of stimulant treatment in children and adults yielded an effect size
averaging almost 1.0. Specifically,65 to 75% of children and adults treated with

stimulants in comparison with 4 to 30% of subjects treated with placebos. Behavioral
treatments have an effect size between .5 and .7(Fabiano,Pelham, Coles, Chronis-
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Tuscano, O'Conner,& Gnagy, 2009). However, it should be noted that there are an

abundance of research on the medical treatment of ADHD compared with that on
behavioral treatments. One of the main reasons for this is that medicaf studies are funded

by the pharmaceutical companies as they stand to lead to profit(Heam,2004).
Given that there is evidence for the efficacy of behavioral treatments for ADHD
as well as concerns regarding the safety of pharmaceutical intervention, it would seem

that there would be a preference of behavior interventions. However, research indicates
that medication seems to be a reasonable and acceptable option for many parents. What

these parents do not realize however, is that their choice of healthcare provider likely
influenced to a great extent the treatment strategy used. Furthermore, parents are not

being fully informed of the risks associated with stimulant treatment. Therefore, it is not
uncommon for a parent to take their child to a pediatrician, who then prescribed
medication without informing the parent about side effects or alternatives such as
behavioral therapies.
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Future Research

Given the complexity of arriving at the diagnosis of ADHD as well as the variety
of different treatment strategies, it is important that there is some standardization between
disciplines. As of now,research has focused on assessing differences within disciplines
(i.e., assessment strategies within different medical specialties, or different type of

psychologists) rather than comparing how psychologists and physicians arrive at the
diagnosis. Furthermore, it seems likely that treatment strategies tend to differ between the
two disciplines. Specifically, pharmaceutical intervention is likely favored by physicians

and behavioral treatment options are probably most often recommended by
psychologists. However, there has yet to be a study published that has examined this
issue. For this reason, a questionnaire was developed by this author for potential use to

survey those individuals who evaluate children for ADHD on a regular basis. This
questionnaire can be found in Appendix B.
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Conclusion

The history of ADKQD as a diagnosis has heen characterized hy ambiguity and a
search for a consensus. According to Lahcy ct al.(1987),"no term in the history of

childhood psychopathology has heen subject to as many rcconccptualizations,
redefinitions, and renamings as the disorder referred to now as ADHD.From its origins
in the concept of minimal brain damage,through hyperkinesis, to attention deficit

disorder with hyperactivity(ADD/H),little has remained constant in our understanding of
this disorder, except the belief that children manifest such a disorder and that we have

never defined it adequately"(p. 330). The latest practice parameters, published by the
AACAP(2007)have tried to respond to some of the questions surrounding ADHD as it
pertains to diagnosis and treatment. Despite this concern for general consensus, there is a
limited amount of current research focusing on how various professional disciplines vary
in their assessment and treatment practices. What is clear from the research in this area is

that there is considerable variability in diagnostic and treatment practices between
disciplines (Handler & DuPaul, 2005).

Research has demonstrated that a "best practice" multi-method approach is the
most comprehensive assessment strategy we currently have. However, the AAP and

AACAP guidelines have proven difficult to put into practice (Rushton, Fant & Clark,

2004). Typical problems with instituting guidelines include unfamiliarity with the
guidelines and/or assessment measures, a lack of awareness of resources, and the amount

of time a thorough diagnosis requires (Leslie et al., 2004). If one is to consider that the

average physician visit lasts roughly 7 to 15 minutes, these best practice approach is
impossible to implement in that setting. It therefore makes more sense to utilize
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psychologists for assessing for ADHD. Not only do psychologists work in a structure in

which they are able to devote several hours to the assessment process, but they also have
advanced training in using the assessment instruments necessary in arriving at a

diagnosis. Furthermore, psychologists are not likely to be influenced by the
pharmaceutical companies when considering treatment options. With these factors in
mind,the following are steps that should be taken by psychologists to ensure they utilize
the best practice approach to the assessment and treatment of ADHD.
To begin, all psychologists who diagnose and/or treat ADHD should be familiar

with both the AACAP guidelines and the DSM-IV criteria. The most efficient approach
when meeting with a concerned parent is to gather a medical,family, social and academic

history that focuses on the DSM-IV criteria for ADHD.Figure 1 provides an illustration

of the diagnostic process (see Appendix A). If significant symptoms of inattention,
impulsivity and/or hyperactivity are present the clinician should assess how they impair
functioning, if they have been present for at least 6 months and if they emerged before

the age of 7. To assess the presence of ADHD behaviors in multiple settings one should
familiarize themselves with several different commonly used behavioral checklists (e.g.,
Conner's, CBCL)and choose the one they best understand and that meets their needs.
Also one needs to consider the scoring process as it can be complicated and/or time

consuming. In addition, behavior checklists should be completed by at least one parent

and the child's teacher to assess for the behavior in multiple settings.

The psychologist also needs to note if any of the child's symptoms can be better
accoimted for by a medical or psychological disorder. If this disorder is out of the
clinician's scope of practice, an appropriate referral should be made for assessment. If
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this disorder is something that the clinician can easily assess and treat, a follow-up

appointment should be scheduled to discuss the results and make changes to the treatment
regimen as needed. Similarly, the clinician needs to assess for possible comorbid
disorders such as a language or learning disorder, which may also require a referral to an
outside source for appropriate assessment.
Parents of those children who do meet die criteria for ADHD as outlined in the

DSM-FV-TR (2000) as assessed using the methods outlined above, should be provided a
range of treatment options including both pharmacological and behavioral options. The

risks of pharmacological treatment should be explained fully. At the time of diagnosis the
parent and child should also receive psychoeducation regarding ADHD.If the parents
desire a treatment that a particular clinician does not provide, an appropriate referral
should be made. Pharmaceutical intervention should appropriately and necessarily be

referred to a physician. And finally, the clinician needs to assess the child's progress in
treatment and make adjustments as needed which can be accomplished using rating scales
from parents and teachers.

In closing, the number of ADHD cases is not likely to decrease any time soon, but
the way in which we diagnose and treat ADHD needs to change. Thus far, the medical
community has largely pushed the idea that ADHD has a biological basis and therefore
the best treatment is medication, but with little evidence. However, what is known about

stimulant treatment for ADHD is troubling. Its use has been linked to impaired growth,

cardiac issues and even death and there is still not much data on the long term effects of
treatment. It is clear that a new approach is needed given these concems over side effects
of stimulant treatment and the pharmaceutical companies' involvement in treatment.
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Psychology seems like the ideal discipline to be diagnosing and treating ADHD,as
psychologists have much more assessment training than physicians and appointments are
typically long enough to accommodate the essentials of a good assessment. As the public
as a whole seems to becoming more aware of ADHD,and the controversial use of

stimulants to treat it, parents are more likely to seek out behavioral treatments. When this
shift occurs, psychologists as a discipline are trained and ready to serve population
ultimately resulting in better ADHD management overall.
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Appendix A
Timeline of Stimulant Treatment for ADHD

First use of stimulants for children's behavioral difficulties

1955

1991

Ritalin (methylphenldate) created

Clba-Gelgy begins contributing $748,000
to CHADD over the next three years

1961
2003

FDA approves Ritalin for use with children
Leading researcher William Pelham
claims Interference from pharmacuetlcal
company In his research

1955

19^ 1961

1I

If

1991

1992

1993

1987
The rate of stimulant treatment rose

five fold over the previous 15 years
191SO

Beginning of aggressive marketing
of ADHD medication to physicians

DEA "shortage" of Ritalin

1940

Pharmacuetlcal firm begins working on medication
for behavioral difficulties In children
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2003

Appendix B
Process for arriving at an ADHD diagnosis.

Yes

No
interview determine if the child

has symptoms of inattention or inhibition and/or

,. hyperactivity that are signtTicant enough to v
impair dailyfunctioning
ip

.

\
■

Have these symptoms
been evident for the
last 6 months'^

Yes

Continue to monitor symptoms
No

Using standardized
behavior checklists, are thi
symptoms evident in at
least two settings

Yes

Yes

I s there another medicar~ ''''
or psychological condition that
for ADHD?

Treat condition and

>-

can better account

' ^

to monitor symptoms

^

No
No

' Have these symptoms
been evident since

' ,,

the age of 7?

>-

Consider a diagnosis of ADHD NOS

T Yes
Make the appropriate ADHD diagnosis j
Combined type

1

Hyperactlvelnattentive Type
Predominantly Inattentive Type

j
t
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Appendix C
Questionnaire

Please take 10 minutes to complete this short questionnaire. Most of this questionnaire can be answered by
checking the appropriate boxes to save you time. Thank you in advance for your participation.
1. Please check one of the following to indicate your primary profession

I I
□
Q
□
□
[]]
□
n
2.

M.D.Psychiatrist
M.D. Pediatrician
M.D. Neurology
M.D. Family practice
University based researcher
Ph.D. Clinical psychologist
Ph.D. Counseling psychology
Ph.D. Family therapy

[] Ph.D. School psychology
Q Ph.D. Counseling psychology
Q ED.D. School psychology
Q ED.D. Education
□ M.A. or M.S. School psychology
□ M.A. or M.S. Family therapist
□ Other (please explain)

How long have you been working in your profession?.

3. Please estimate what percentage of the professional time you spend working with children, adolescents
or adults who come to you for services primarily for problems involving attention and/or hyperactivity:

4. Please check the following items that you believe are necessary for an accurate diagnosis of ADHD:
n
[~1
n
r~|

n
n
□
|~1
□

Patient meets all DSM-IV criteria
Patient Interview
Parent Interview
Teacher Interview

Have parents fill out a scale or assessment instruments (e.g., Auchenbach, Conners)
Have teacher fill out a scale or assessment instruments (e.g., Auchenbach, Conners)
Gather information from multiple sources (e.g., school, counselor, coach, etc.)
Educational assessment - reading, writing and math skills.
Cognitive assessment (e.g., WISC-III, K-BIT)

I I CPT (Continuous Performance Test)

Q] Observation of parental interactions with child.
Q Observation of teacher/student interaction
n Assessment of martial satisfaction and life stressors.

n Assessment of parental discipline techniques, consistency, styles, etc.

I I Assessment of parental drug/alcohol abuse, domestic violence, and/or child abuse.
r~| Developmental history
r~l Psychosocial history

r~| Medical history
n Medical exam

|~|
r~|
□
n
□
[]]
r~|

Speech evaluation.
Hearing evaluation.
Vision exam.
Neurological exam
Neurological testing (e.g., PET, SPECT, FMRI)
Blood work
Other (please specify):
.
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5. When a patient comes to your office/work who presents with symptoms of ADHD, what are diagnoses
do you consider?
a.

b.
c.

In your work with ADHD patients, what do you consider to be the most powerful diagnostic tool,
assessment, or observation for determining the presence of ADHD?
6. Do you know of any psychological or educational diagnostic tests that are reliable and valid in
diagnosing ADHD?

Yes □

No □

If yes, please list them (in descending order of
helpfulnes s):

7.

Do you believe ADHD or ADD has a genetic component?

Yes □

No □

If yes, please list at least 2 or 3 research studies you feel helps substantiate this
position:__
'

How would this genetic component be assessed?.

8. If you believe ADHD is the result of an interaction between genetic and environmental factors, what
percentage of contribution would you give to the following factors.
Genetic

Family
School

Other environmental factors (e.g., SES)

9.

Do you believe that ADHD or ADD is caused by some type of biochemical imbalance?

Yes □

No □

If yes, please list at least 2 or 3 research studies you feel helps substantiate this position:

How would you assess a biochemical imbdance related to ADHD (e.g., would you refer out, who
would you refer to, what test(s) would you use use)?
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10. Do you believe ADHD or ADD is caused by a neurotransmitter deficit?

Yes □

No □

If yes, please list at least 2 or 3 research studies you feel best substantiate this position:

How would you assess a neurotransmitter deficit in relation to ADHD?

11. Do you believe ADHD or ADD is a biologically or medically caused disorder?

Yes □

No □

If yes, please list at least 2 or 3 research studies you feel best substantiate this
position:
^

How would you assess the biological or medical component to ADHD?

12. To the best of your knowledge, is there any medical diagnostic procedure or test (e.g., CAT scans, PET
scans, MKTs, blood tests, genetic tests, etc.) that could accurately differentiate a child with ADHD
from one without ADHD.

Yes □

No □

If yes, please indicate the specific test(s) or procedure(s):_

13. What is your typical treatment plan for a child with an ADHD diagnosis (check all that apply)?

Individual Therapy
n
I I
[~|
□
IX]

Cognitive behavioral
Gestalt
Play Therapy
Biofeedback
Other:

Family Therapy
Q

Q
□
[X]
□
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Brief family intervention
XH Functional family therapy
Structural family therapy
Strategic family therapy
Solution oriented family therapy
Other:
^
^

School/Teacher Intervention

Social Skills Training

□ Assertive discipline
Q Behavior modification
[~1 Positive discipline

Q Goldstein
Q Parent training workshops
Q Other:

n Adlerian

□ Jones and James
□ Glasser
□ Modification of classroom
environment

□ Modification of instruction or
curriculum

□ Other:

Medication

n
n
□
r~1
n
Q
□
n

Methlphenidate (Ritalin, Ritalin-SR)
D-Amphetamine (Dexedrine, Dexedrine spanules)
Pemoline (Cylert)
Bupropion (Wellbutrin)
Tricyclic antidepressants
Venlafaxine (Effexor)
MAOI - tranylcypromine (Pamate), Selegiline (Eldepryl)
Fluoxetine - Prozac

15. What is your primary method of treatment?

□ Child based
□ Family based
□ School based
16. Do you have a specific amount of time before medication is considered?

n
□
□
Q
r~|

Typically, medications are recommended right away.
Yes, 2-4 months
Yes, 4-6 months
Yes, 6 months to 1 year
Other (please provide a specific amount of time before you consider the use of

medications):_

^
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